AFP and hepatocellular carcinoma: Hiraki et al. (29) indicated that no viable intrahepatic recurrence, no liver cirrhosis, Child–Pugh A class, and serum AFP level lower than 10 ng/ml were associated with better survival for patients with pulmonary metastases from HCC undergoing percutaneous RFA.